<DOC>
	<DOCNO>NCT01536249</DOCNO>
	<brief_summary>This study assess effect cimetidine pharmacokinetics ( PK ) dexpramipexole healthy volunteer evaluate safety tolerability dexpramipexole give without cimetidine . Additionally , study explore influence genetic variation PK dexpramipexole give without cimetidine .</brief_summary>
	<brief_title>Dexpramipexole Cimetidine Drug Drug Interaction ( DDI )</brief_title>
	<detailed_description>This single-center , open-label , randomize , two-period , crossover study approximately 14 healthy subject . The goal study follow : To assess effect cimetidine pharmacokinetics ( PK ) dexpramipexole healthy volunteer . To evaluate safety tolerability dexpramipexole give without cimetidine . To explore influence genetic variation PK dexpramipexole give without cimetidine .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Subjects , opinion Investigator , healthy determine medical history , physical examination , 12 lead ECG Adult males/females age 18 55 year inclusive Male female subject childbearing potential must practice effective contraception study 90 day last dose . History malignant disease , include solid tumor hematologic malignancy . History clinically significant endocrine , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , major disease , determine Investigator . Treatment prescription medication and/or overthecounter product herbalcontaining and/or alternative health preparation procedure . Surgery within 90 day prior checkin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>